Research Archives | Surviving Mesothelioma

Age May Have Little Impact on Mesothelioma Surgery Outcomes

Being older does not necessarily reduce a patient’s odds of benefiting from mesothelioma surgery. That is the good news from a study conducted by mesothelioma experts at Glenfield Hospital in Leicester, England. The bad news is that too many elderly mesothelioma patients are not being referred for adjuvant treatments that could improve their surgical outcomes. Adjuvant Therapy and Mesothelioma Survival Adjuvant therapy is a treatment … Continue reading Age May Have Little Impact on Mesothelioma Surgery Outcomes »

Mesothelioma Biomarker Test May Be Diagnostic Alternative for Frail Patients

A set of proteins found in the lung fluid of people with malignant pleural mesothelioma may offer a safer way to diagnose the asbestos cancer in frail or elderly patients. Mesothelioma is an extremely difficult cancer to diagnose. Accurate diagnosis usually requires a combination of tests including a physical exam, a thorough work history (including possible asbestos exposure), blood or lung fluid tests, imaging scans, … Continue reading Mesothelioma Biomarker Test May Be Diagnostic Alternative for Frail Patients »

New Chemotherapy Technique Carries Risks for Peritoneal Mesothelioma Patients

A new way of delivering chemotherapy drugs to the site of a peritoneal mesothelioma tumor has some unique benefits, but can also be risky. The technique, called pressurized intraperitoneal aerosol chemotherapy (PIPAC) allows doctors to “spray” a solution of chemotherapy drugs directly onto peritoneal tumors through small ports in the abdomen. The intention is to uniformly coat the tumor and help keep chemotherapy drugs in … Continue reading New Chemotherapy Technique Carries Risks for Peritoneal Mesothelioma Patients »

Mesothelioma Patients May Benefit from ‘Aesthetic Support’

When it comes to coping with the treatment and side effects of a cancer like malignant mesothelioma, looks matter – especially to female patients. That is the message of a new Italian study on the impact of an “aesthetic care” program for hospitalized cancer patients. The objective of the study, published in the journal Frontiers in Psychology, was to evaluate a support program called “Health … Continue reading Mesothelioma Patients May Benefit from ‘Aesthetic Support’ »

Mesothelioma Survivors May Not Have Enough Knowledge of Nutrition

New evidence suggests that too many long-term survivors of malignant mesothelioma and other cancers may not be following the dietary guidelines that could keep them healthy for a lifetime. Researchers from Johns Hopkins and Drexel University recently analyzed the diets of 53 adult cancer survivors and found that many are not adequately prepared to follow a cancer-preventing diet indefinitely. Mesothelioma Survival and DIet Multiple studies … Continue reading Mesothelioma Survivors May Not Have Enough Knowledge of Nutrition »

Sickest Mesothelioma Patients May Benefit Most from P/D Surgery

Patients with the worst cases of malignant pleural mesothelioma may stand to gain the most from pleurectomy and decortication (P/D) surgery. That is the conclusion of researchers at the University of Chicago and Loyola University who subjected 114 mesothelioma patients to a quality of life and overall health scoring system both before and after P/D surgery.   Considering Mesothelioma Surgery The decision on whether or … Continue reading Sickest Mesothelioma Patients May Benefit Most from P/D Surgery »

Radical Surgery Alone Unlikely to Prolong Mesothelioma Survival

Extrapleural pneumonectomy, the most radical – and risky – type of surgery for malignant pleural mesothelioma, is more likely to lead to long term survival when paired with strategic follow-up treatments. That is the conclusion of researchers at Japan’s Kyushu University who conducted a retrospective study of 10 mesothelioma patients who underwent EPP at their institution between 2001 to 2010. EPP Surgery and Mesothelioma Outcomes … Continue reading Radical Surgery Alone Unlikely to Prolong Mesothelioma Survival »

Inflammation Marker May Predict Mesothelioma Prognosis

The ratio of neutrophils to lymphocytes – a way of measuring inflammation in the body of people with malignant pleural mesothelioma – may help doctors predict how well they will respond to treatment. That is the conclusion of mesothelioma researchers at China’s Sichuan University. In a new article in the journal Oncotarget, the team observed that NLR has been associated with survival in other types … Continue reading Inflammation Marker May Predict Mesothelioma Prognosis »

New Chemotherapy Booster May Extend Mesothelioma Survival

Cancer researchers say the VEGF-inhibitor nintedanib (Ofev) extended mesothelioma survival by more than five months in patients on standard chemotherapy in a new trial. That is among the findings of a recently-published Phase II study of nintedanib as an adjunct therapy to pemetrexed (Alimta) and cisplatin for malignant pleural mesothelioma. Nintedanib Trial Details Nintedanib is currently used to treat idiopathic pulmonary fibrosis and some types … Continue reading New Chemotherapy Booster May Extend Mesothelioma Survival »

Mesothelioma Incidence Unaffected by Ambient Asbestos in Cities

City dwellers are no more likely to contract malignant pleural mesothelioma from asbestos dust in the air than people who live in rural areas – even though there is more asbestos dust in cities. That is the conclusion of a new study published in the journal Risk Analysis. The study was based on the fact that so-called “ambient asbestos”, or asbestos fibers that are free … Continue reading Mesothelioma Incidence Unaffected by Ambient Asbestos in Cities »

Get your free copy of
“Surviving Mesothelioma” Today!